Komor A, Goncharov N P, Oettel M
Endokrinologie. 1982 Jul;79(3):428-30.
STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one) or levonorgestrel was given orally as a single dose of 0.4 mg per animal. Treatment was performed immediately after the 6 h mating period. In 30 control cycles (18 animals) 9 pregnancies (30%) and in 26 cycles (17 animals) with levonorgestrel treatment 3 pregnancies (11.5%) were observed. In 46 cycles (21 animals) with STS 557 treatment only one pregnancy (2.2%) occurred (chi 2-test: P less than 0.01 as compared to control cycles). Therefore, STS 557 showed high interceptive activities in this nonhuman primate model. In contrast with levonorgestrel, STS 557 did not decrease the postovulatory rise of plasma progesterone.
给每只动物口服单剂量0.4毫克的STS 557(17α-氰甲基-17β-羟基-雌甾-4,9(10)-二烯-3-酮)或左炔诺孕酮。在6小时交配期后立即进行治疗。在30个对照周期(18只动物)中观察到9次妊娠(30%),在26个接受左炔诺孕酮治疗的周期(17只动物)中观察到3次妊娠(11.5%)。在46个接受STS 557治疗的周期(21只动物)中仅发生1次妊娠(2.2%)(卡方检验:与对照周期相比,P<0.01)。因此,STS 557在该非人灵长类动物模型中表现出高避孕活性。与左炔诺孕酮不同,STS 557并未降低排卵后血浆孕酮的升高。